Center for Scientific Review; Amended Notice of Meeting, 68461 [2013-27172]

Download as PDF Federal Register / Vol. 78, No. 220 / Thursday, November 14, 2013 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–1994–D–0007] Guidance for Industry: Studies To Evaluate the Utility of Anti-Salmonella Chemical Food Additives in Feeds; Request for Comments AGENCY: Food and Drug Administration, HHS. ACTION: Request for comments. The Food and Drug Administration (FDA) is considering revising the guidance entitled ‘‘Guidance for Industry: Studies to Evaluate the Utility of Anti-Salmonella Chemical Food Additives in Feeds,’’ and is seeking comments on this guidance before revisions are made. DATES: Submit electronic or written comments by January 13, 2014. ADDRESSES: Submit written requests for single copies of the guidance to the Communications Staff (HFV–12), Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855. Send one selfaddressed adhesive label to assist that office in processing your requests. See the SUPPLEMENTARY INFORMATION section for electronic access to the guidance document. Submit electronic comments to https://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Xin Li, Center for Veterinary Medicine (HFV–222), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240–453–6863, xin.li@fda.hhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: TKELleY on DSK3SPTVN1PROD with NOTICES I. Background One of the key objectives of Guidance for Industry: Studies to Evaluate the Utility of Anti-Salmonella Chemical Food Additives in Feeds (GFI #80) is to help sponsors design efficacy studies to support the submission of Food Additive Petitions (FAPs) for food additives intended for anti-Salmonella use in food for animals. We would like to revise GFI #80 because science, technology, and FDA policy have changed since this guidance was last revised. GFI #80 currently addresses only chemical food additives intended to maintain feeds or feed ingredients Salmonella-negative. We intend to VerDate Mar<15>2010 19:20 Nov 13, 2013 Jkt 232001 expand the scope of this guidance to address other categories of food additives beyond chemical food additives, and to cover all food for animals, including pet food. Before we revise the content of GFI #80 we intend to consider your answers to the following questions: 1. What intended technical effects can we expect to see in FAPs submitted to FDA for anti-Salmonella use of the food additives in food for animals? 2. How should efficacy studies be designed for the intended technical effects described in your response to question 1? 3. Should experimental lots of animal food used in both laboratory and field studies be Salmonella-negative, but not sterile, prior to inoculation? 4. What inoculation levels of Salmonella are appropriate for experimental lots of animal food used in laboratory and field studies? Please justify your comment with scientific evidence. 5. What methods should be used to inoculate experimental lots of animal food used in laboratory and field studies? 6. What sampling criteria should be used to provide statistical confidence that Salmonella will be captured among samples collected? Please justify your comment with scientific evidence. 7. What methods should be used to enumerate the level(s) of Salmonella in animal food? 8. What are the key elements for designing field studies? 9. What are the difficulties faced by sponsors when designing and conducting field studies? 10. What types of facilities are available to conduct field studies? Electronic versions of GFI #80 are in the docket at https://www.regulations.gov and on FDA’s Web site at https:// www.fda.gov/AnimalVeterinary/ GuidanceComplianceEnforcement/ GuidanceforIndustry/default.htm. II. Comments Interested persons may submit either electronic comments regarding this document to https://www.regulations.gov or written comments to the Division of Dockets Management (see ADDRESSES). It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at https:// www.regulations.gov. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 68461 Dated: November 5, 2013. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2013–27194 Filed 11–13–13; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, December 04, 2013, 01:00 p.m. to December 04, 2013, 05:00 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on November 05, 2013, 78 FR 214 Pg. 66371. The meeting will start on December 3, 2013 at 12:00 p.m. and end December 3, 2013 at 5:00 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: November 7, 2013. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27172 Filed 11–13–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Fellowships and Dissertations. Date: December 6, 2013. Time: 2:00 p.m. to 5:00 p.m. E:\FR\FM\14NON1.SGM 14NON1

Agencies

[Federal Register Volume 78, Number 220 (Thursday, November 14, 2013)]
[Notices]
[Page 68461]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27172]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, December 04, 2013, 01:00 p.m. 
to December 04, 2013, 05:00 p.m., National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892 which was published in the Federal 
Register on November 05, 2013, 78 FR 214 Pg. 66371.
    The meeting will start on December 3, 2013 at 12:00 p.m. and end 
December 3, 2013 at 5:00 p.m.
    The meeting location remains the same. The meeting is closed to the 
public.

    Dated: November 7, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-27172 Filed 11-13-13; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.